364 related articles for article (PubMed ID: 15932949)
1. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.
Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8299-302. PubMed ID: 15932949
[TBL] [Abstract][Full Text] [Related]
2. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.
Reiman EM; Caselli RJ; Chen K; Alexander GE; Bandy D; Frost J
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3334-9. PubMed ID: 11248079
[TBL] [Abstract][Full Text] [Related]
3. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
[TBL] [Abstract][Full Text] [Related]
4. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.
Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):284-9. PubMed ID: 14688411
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
6. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.
Reiman EM; Chen K; Langbaum JB; Lee W; Reschke C; Bandy D; Alexander GE; Caselli RJ
Neuroimage; 2010 Jan; 49(1):169-76. PubMed ID: 19631758
[TBL] [Abstract][Full Text] [Related]
7. Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.
Chen K; Ayutyanont N; Langbaum JB; Fleisher AS; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Caselli RJ; Reiman EM
Neuroimage; 2012 May; 60(4):2316-22. PubMed ID: 22348880
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions.
Reiman EM; Chen K; Caselli RJ; Alexander GE; Bandy D; Adamson JL; Lee W; Cannon A; Stephan EA; Stephan DA; Papassotiropoulos A
Neuroimage; 2008 Apr; 40(3):1214-21. PubMed ID: 18280754
[TBL] [Abstract][Full Text] [Related]
9. Glucose metabolism and gray-matter concentration in apolipoprotein E ε4 positive normal subjects.
Samuraki M; Matsunari I; Chen WP; Shima K; Yanase D; Takeda N; Matsuda H; Yamada M
Neurobiol Aging; 2012 Oct; 33(10):2321-3. PubMed ID: 22188720
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
[TBL] [Abstract][Full Text] [Related]
11. Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.
Nielsen HM; Chen K; Lee W; Chen Y; Bauer RJ; Reiman E; Caselli R; Bu G
Alzheimers Res Ther; 2017 Jan; 9(1):5. PubMed ID: 28137305
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations.
Tamashiro-Duran JH; Squarzoni P; de Souza Duran FL; Curiati PK; Vallada HP; Buchpiguel CA; Lotufo PA; Wajngarten M; Menezes PR; Scazufca M; de Toledo Ferraz Alves TC; Busatto GF
Age (Dordr); 2013 Jun; 35(3):777-92. PubMed ID: 22544617
[TBL] [Abstract][Full Text] [Related]
13. Cerebral glucose metabolism in patients with AD and different APOE genotypes.
Drzezga A; Riemenschneider M; Strassner B; Grimmer T; Peller M; Knoll A; Wagenpfeil S; Minoshima S; Schwaiger M; Kurz A
Neurology; 2005 Jan; 64(1):102-7. PubMed ID: 15642911
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease.
Mielke R; Zerres K; Uhlhaas S; Kessler J; Heiss WD
Neurosci Lett; 1998 Sep; 254(1):49-52. PubMed ID: 9780089
[TBL] [Abstract][Full Text] [Related]
15. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.
Hirono N; Hashimoto M; Yasuda M; Ishii K; Sakamoto S; Kazui H; Mori E
Neurology; 2002 Mar; 58(5):743-50. PubMed ID: 11889238
[TBL] [Abstract][Full Text] [Related]
16. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.
Høgh P; Knudsen GM; Kjaer KH; Jørgensen OS; Paulson OB; Waldemar G
J Geriatr Psychiatry Neurol; 2001; 14(1):42-51. PubMed ID: 11281316
[TBL] [Abstract][Full Text] [Related]
17. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.
Mosconi L; Herholz K; Prohovnik I; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Sorbi S; Pupi A
J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):15-23. PubMed ID: 15607989
[TBL] [Abstract][Full Text] [Related]
18. Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele).
Scarmeas N; Habeck C; Anderson KE; Hilton J; Devanand DP; Pelton GH; Tabert MH; Flynn J; Park A; Ciappa A; Tycko B; Stern Y
Am J Geriatr Psychiatry; 2004; 12(6):596-605. PubMed ID: 15545327
[TBL] [Abstract][Full Text] [Related]
19. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
